Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Sarcoma × liposomal doxorubicin × 30 days × Clear all

Sponsor

Conditions

Ovarian Neoplasms 8 Fallopian Tube Neoplasms 5 Breast Neoplasms 4 Triple Negative Breast Neoplasms 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Neoplasms 2 Neoplasm Metastasis 2 Multi-centric Castleman's Disease 2 Vaccinia 1 Sarcoma, Kaposi 1 Sarcoma, Ewing 1 Macular dystrophy, corneal type 1 1 Lymphoproliferative Disorders 1 Lymphadenopathy 1 Low Grade Serous Ovarian Cancer 1 Hodgkin Disease 1 HIV Infections 1 Acquired Immunodeficiency Syndrome 1

Interventions

Specimen Handling 6 Cyclophosphamide 5 Biopsy 5 Temozolomide 4 Radiotherapy 4 Magnetic Resonance Spectroscopy 4 pazopanib 3 X-Rays 3 Vincristine 3 Trabectedin 3 Irinotecan 3 Ifosfamide 3 Doxorubicin 3 regorafenib 2 pembrolizumab 2 fludarabine 2 atezolizumab 2 Sirolimus 2 Radiation 2 Phantoms, Imaging 2 Metastasectomy 2 Gemcitabine 2 Etoposide 2 trastuzumab deruxtecan 1 tivozanib 1 temsirolimus 1 tazemetostat 1 talimogene laherparepvec 1 selinexor 1 polyethylene glycol 8000 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡